CoreMap, a company developing high-resolution mapping technology for heart rhythm disorders, has raised 37 million US dollars in a Series B round led by Medtronic.
In the same week, London-based Scarlet, which builds regulatory compliance infrastructure for AI and software as a medical device, closed a 50 million dollar round, reflecting growing investment in medical-AI regulation under the EU AI Act.















